Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Cambridge, MA.
Department of Pathology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA.
Clin Chem. 2018 Apr;64(4):705-714. doi: 10.1373/clinchem.2017.280685. Epub 2018 Jan 16.
Copy number variants (CNVs) can substantially contribute to the pathogenic variant spectrum in several disease genes. The detection of this type of variant is complicated in genes with high homology to other genomic sequences, yet such genomics regions are more likely to lead to CNVs, making it critical to address detection in these settings.
We developed a copy number analysis approach for high homology genes/regions that consisted of next-generation sequencing (NGS)-based dosage analysis accompanied by allele-specific droplet digital PCR (ddPCR) confirmatory testing. We applied this approach to copy number analysis in , a gene with 98.9% homology to a nonfunctional pseudogene, , and characterized its accuracy in detecting different copy number states by use of known samples.
Using a cohort of 517 patients with hearing loss, we prospectively demonstrated the clinical utility of the approach, which contributed 30 of the 122 total positives (6%) to the diagnostic yield, increasing the overall yield from 17.6% to 23.6%. Positive genotypes included homozygous (n = 15) or compound heterozygous (n = 8) deletions, or heterozygous deletions with pathogenic sequence variants (n = 7). Finally, this approach limited ddPCR testing to cases with NGS copy number findings, thus markedly reducing the number of costly and laborious, albeit specific, ddPCR tests.
NGS-based CNV detection followed by allele-specific ddPCR confirmatory testing is a reliable and affordable approach for copy number analysis in medically relevant genes with homology issues.
拷贝数变异(CNVs)在多个疾病基因的致病变异谱中起着重要作用。在与其他基因组序列高度同源的基因中检测这种类型的变异很复杂,但这些基因组区域更容易导致 CNVs,因此在这些情况下进行检测至关重要。
我们开发了一种针对高度同源基因/区域的拷贝数分析方法,该方法包括基于下一代测序(NGS)的剂量分析,以及等位基因特异性液滴数字 PCR(ddPCR)确认测试。我们将这种方法应用于与无功能假基因高度同源的基因 中的拷贝数分析,该基因与 的同源性为 98.9%,并通过使用已知样本来描述其检测不同拷贝数状态的准确性。
使用 517 名听力损失患者的队列,我们前瞻性地证明了该方法的临床实用性,该方法对 122 个总阳性(6%)中的 30 个做出了贡献,将总阳性率从 17.6%提高到 23.6%。阳性 基因型包括纯合子(n = 15)或复合杂合子(n = 8)缺失,或杂合子缺失与致病性序列变异(n = 7)。最后,这种方法将 ddPCR 测试限制在 NGS 拷贝数发现的情况下,从而显著减少了昂贵且费力但具有特异性的 ddPCR 测试的数量。
基于 NGS 的 CNV 检测,随后进行等位基因特异性 ddPCR 确认测试,是一种可靠且经济实惠的方法,适用于具有同源性问题的医学相关基因中的拷贝数分析。